Viewbix Inc. (Nasdaq: VBIX), a marketing technologies company, has announced a comprehensive corporate rebranding to Quantum X Labs Inc. (“Quantum X Labs”). This follows Viewbix’s acquisition of Quantum X Labs Ltd. in March 2026, which is now a wholly-owned subsidiary. The Company is expected to change its name to Quantum X Labs Inc. and its ticker symbol to “QXL”, effective April 30th, 2026.
Followig the rebranding, Viewbix will aim to develop and own quantum computing and error correction technologies (currently with a pending patent for AI-Quantum Error Correction), quantum simulations and quantum sensing technologies, while continuing its legacy digital advertising activities as a business segment.
According to the press release, the new name and brand aims to position Quantum X Labs as a leading company to research, develop, and potentially commercialize innovative quantum solutions across key sectors, including navigation, precision timing, quantum algorithms, quantum error correction, drug discovery, biomedicine, nuclear simulation, transportation, and quantum cyber security.
Quantum X Labs Ltd.’s portfolio companies include:
Quantum Gyro: developing quantum-based gyroscope chip technology for unjammable, high-precision navigation systems designed to operate in GPS-denied environments. Quantum Gyro is a 40%-owned subsidiary of Quantum X Labs Ltd.
Quantum Atom Accuracy: advancing next-generation atomic clocks based on novel light-modulation schemes to deliver ultra-high accuracy, robustness, and enhanced coherence for precision timing solutions. Quantum Atom Accuracy is a wholly-owned subsidiary of Nuclear Quantum.
Nuclear Quantum: progressing quantum-powered simulation algorithms targeted at nuclear and engineering industries, with recent milestones moving toward commercial engagement with leading simulation providers. Nuclear Quantum is a 40%-owned subsidiary of Quantum X Labs.
QuantumQ Security: working on protecting assets by using quantum based cyber security. QuantumQ Security is a wholly-owned subsidiary of Quantum Gyro.
Quantum Transportation: developing transformer-based quantum decoder technology for advanced quantum error correction, including cloud-deployed neural decoders and IP licensing from Ramot at Tel Aviv University, with applications in transportation and secure systems. Quantum Transportation is a 30%-owned subsidiary of Quantum X Labs.
CliniQuantum: applying quantum-enhanced methods (such as Markov Chain Monte Carlo) to drug discovery, clinical trial optimization, logistics, biomedicine, and security sectors. CliniQuantum is a 46%-owned subsidiary of Quantum X Labs.
This rebranding builds on a series of technical milestones achieved by its portfolio companies in recent months, including patent filings, prototype breakthroughs in quantum gyroscopes and atomic clocks, and progress in quantum simulation and error-correction algorithms.
While advancing its quantum innovation, the company will continue to support its legacy business of digital advertising and AI-driven computing solutions, through its subsidiaries Gix Media Ltd. and Metagramm Software Ltd., which complement its expanding quantum portfolio.
